β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis

Toshio Miyata, Osamu Oda, Reiko Inagi, Yoshiyasu Iida, Norie Araki, Norio Yamada, Seikoh Horiuchi, Naoyuki Taniguchi, Kenji Maeda, Taroh Kinoshita

Research output: Contribution to journalArticlepeer-review

403 Citations (Scopus)

Fingerprint

Dive into the research topics of 'β<sub>2</sub>-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis'. Together they form a unique fingerprint.

Medicine & Life Sciences